14-day Premium Trial Subscription Try For FreeTry Free
Date Action Amount Person Type
Apr 01, 2024 Sell 50 000 Coles N Anthony Stock Option (Right to Buy)
Apr 01, 2024 Buy 50 000 Coles N Anthony Common Stock
Apr 01, 2024 Sell 50 000 Coles N Anthony Common Stock
Mar 04, 2024 Sell 50 000 Coles N Anthony Stock Option (Right to Buy)
Mar 04, 2024 Buy 50 000 Coles N Anthony Common Stock
Mar 04, 2024 Sell 50 000 Coles N Anthony Common Stock
Feb 29, 2024 Sell 50 000 Coles N Anthony Stock Option (Right to Buy)
Feb 29, 2024 Buy 50 000 Coles N Anthony Common Stock
Feb 29, 2024 Sell 50 000 Coles N Anthony Common Stock
Feb 20, 2024 Sell 170 317 Perceptive Advisors Llc Common Stock
Feb 07, 2024 Sell 2 161 Renger John Common Stock
Feb 07, 2024 Sell 2 506 Coles N Anthony Common Stock
Feb 06, 2024 Sell 5 020 Renger John Restricted Stock Units
Feb 06, 2024 Buy 5 020 Renger John Common Stock
Feb 06, 2024 Sell 15 440 Coles N Anthony Restricted Stock Units
Feb 06, 2024 Buy 15 440 Coles N Anthony Common Stock
Jan 19, 2024 Buy 81 065 Altschuller Susan Restricted Stock Units
Jan 19, 2024 Buy 87 573 Renger John Restricted Stock Units
Jan 19, 2024 Buy 59 171 Tregoning Kathleen Restricted Stock Units
Jan 19, 2024 Buy 63 905 Dipietro Kenneth Restricted Stock Units
Jan 19, 2024 Buy 24 852 Bodenrader Mark Restricted Stock Units
Jan 19, 2024 Buy 81 065 Burgess Paul D. Restricted Stock Units
Jan 19, 2024 Buy 87 573 Sanchez Ramiro Restricted Stock Units
Jan 19, 2024 Buy 284 023 Renaud Ronald C Jr Restricted Stock Units
Jan 19, 2024 Buy 59 171 Akamine Scott Restricted Stock Units
Jan 02, 2024 Sell 50 000 Coles N Anthony Stock Option (Right to Buy)
Jan 02, 2024 Buy 50 000 Coles N Anthony Common Stock
Jan 02, 2024 Sell 50 000 Coles N Anthony Common Stock
Dec 31, 2023 Buy 0 Sulzberger Gabrielle
Dec 26, 2023 Sell 3 150 Tregoning Kathleen Stock Option (Right to Buy)
Dec 26, 2023 Buy 3 150 Tregoning Kathleen Common Stock
Dec 26, 2023 Sell 10 000 Sanchez Ramiro Stock Option (Right to Buy)
Dec 26, 2023 Buy 10 000 Sanchez Ramiro Common Stock
Dec 26, 2023 Sell 10 000 Sanchez Ramiro Common Stock
Dec 22, 2023 Sell 8 000 Dipietro Kenneth Stock Option (Right to Buy)
Dec 22, 2023 Buy 8 000 Dipietro Kenneth Common Stock
Dec 22, 2023 Sell 8 000 Dipietro Kenneth Common Stock
Dec 20, 2023 Sell 7 889 Bodenrader Mark Common Stock
Dec 20, 2023 Sell 6 256 Dipietro Kenneth Common Stock
Dec 20, 2023 Sell 7 072 Akamine Scott Common Stock
Dec 20, 2023 Sell 10 152 Sanchez Ramiro Common Stock
Dec 20, 2023 Sell 13 808 Altschuller Susan Common Stock
Dec 20, 2023 Sell 6 288 Tregoning Kathleen Common Stock
Dec 19, 2023 Buy 5 085 Bodenrader Mark Common Stock
Dec 19, 2023 Buy 14 199 Bodenrader Mark Common Stock
Dec 19, 2023 Sell 5 085 Bodenrader Mark Restricted Stock Units
Dec 19, 2023 Buy 23 847 Burgess Paul D. Common Stock
Dec 19, 2023 Sell 23 847 Burgess Paul D. Restricted Stock Units
Dec 19, 2023 Buy 13 913 Dipietro Kenneth Common Stock
Dec 19, 2023 Sell 13 913 Dipietro Kenneth Restricted Stock Units
Dec 19, 2023 Buy 13 796 Akamine Scott Common Stock
Dec 19, 2023 Sell 13 796 Akamine Scott Restricted Stock Units
Dec 19, 2023 Buy 160 452 Renaud Ronald C Jr Common Stock
Dec 19, 2023 Sell 160 452 Renaud Ronald C Jr Restricted Stock Units
Dec 19, 2023 Buy 24 825 Sanchez Ramiro Common Stock
Dec 19, 2023 Sell 24 825 Sanchez Ramiro Restricted Stock Units
Dec 19, 2023 Buy 30 721 Altschuller Susan Common Stock
Dec 19, 2023 Sell 30 721 Altschuller Susan Restricted Stock Units
Dec 19, 2023 Buy 13 804 Tregoning Kathleen Common Stock
Dec 19, 2023 Sell 13 804 Tregoning Kathleen Restricted Stock Units
Dec 15, 2023 Sell 7 500 Sanchez Ramiro Stock Option (Right to Buy)
Dec 15, 2023 Buy 7 500 Sanchez Ramiro Common Stock
Dec 15, 2023 Sell 7 500 Sanchez Ramiro Common Stock
Dec 07, 2023 Sell 10 000 Sanchez Ramiro Stock Option (Right to Buy)
Dec 07, 2023 Buy 10 000 Sanchez Ramiro Common Stock
Dec 07, 2023 Sell 10 000 Sanchez Ramiro Common Stock
Dec 07, 2023 Sell 10 000 Akamine Scott Stock Option (Right to Buy)
Dec 07, 2023 Buy 10 000 Akamine Scott Common Stock
Dec 07, 2023 Sell 10 000 Akamine Scott Common Stock
Dec 05, 2023 Sell 7 500 Akamine Scott Stock Option (Right to Buy)
Dec 05, 2023 Buy 7 500 Akamine Scott Common Stock
Dec 05, 2023 Sell 7 500 Akamine Scott Common Stock
Nov 14, 2023 Sell 22 824 Coles N Anthony Stock Option (Right to Buy)
Nov 14, 2023 Buy 22 824 Coles N Anthony Common Stock
Nov 14, 2023 Sell 22 824 Coles N Anthony Common Stock
Nov 08, 2023 Sell 100 Coles N Anthony Stock Option (Right to Buy)
Nov 08, 2023 Buy 100 Coles N Anthony Common Stock
Nov 08, 2023 Sell 100 Coles N Anthony Common Stock
Nov 07, 2023 Sell 27 076 Coles N Anthony Stock Option (Right to Buy)
Nov 07, 2023 Buy 27 076 Coles N Anthony Common Stock
Nov 07, 2023 Sell 27 076 Coles N Anthony Common Stock
Nov 03, 2023 Sell 61 401 Coles N Anthony Stock Option (Right to Buy)
Nov 03, 2023 Buy 61 401 Coles N Anthony Common Stock
Nov 03, 2023 Sell 61 401 Coles N Anthony Common Stock
Nov 02, 2023 Sell 38 599 Coles N Anthony Stock Option (Right to Buy)
Nov 02, 2023 Buy 38 599 Coles N Anthony Common Stock
Nov 02, 2023 Sell 38 599 Coles N Anthony Common Stock
Nov 01, 2023 Buy 30 130 Patrick Deval L Common Stock
Nov 01, 2023 Sell 30 130 Patrick Deval L Stock Option (Right to Buy)
Nov 01, 2023 Sell 30 130 Patrick Deval L Common Stock
Oct 16, 2023 Buy 5 480 052 Gordon Christopher R Common Stock
Oct 16, 2023 Buy 5 480 052 Koppel Adam Common Stock
Oct 16, 2023 Buy 5 480 052 Bain Capital Investors Llc Common Stock
Oct 16, 2023 Buy 876 808 Perceptive Advisors Llc Common Stock
Sep 07, 2023 Sell 50 000 Coles N Anthony Stock Option (Right to Buy)
Sep 07, 2023 Buy 50 000 Coles N Anthony Common Stock
Sep 07, 2023 Sell 50 000 Coles N Anthony Common Stock
Aug 04, 2023 Buy 21 880 Burgess Paul D. Common Stock
Aug 03, 2023 Buy 83 857 Renaud Ronald C Jr Common Stock
Jul 11, 2023 Sell 50 000 Coles N Anthony Stock Option (Right to Buy)
INSIDER POWER
79.945
Last 100 transactions
Buy: 19 058 481 | Sell: 1 552 762 (Shares)

Based on the 100 latest insides trades, we have calculated the insider power to be positive at a ratio of 79.945.

In total, the insiders bought 19 058 481 and sold 1 552 762 CERE shares in the last 100 trades.

Click to get the best stock tips daily for free!

About Cerevel Therapeutics Holdings, Inc.

Cerevel Therapeutics Holdings. Cerevel Therapeutics Holdings, Inc., a clinical-stage biopharmaceutical company, engages in the development of various therapies for neuroscience diseases. It is developing emraclidine, a positive allosteric modulator (PAM) that is in phase 1b clinical trials for the treatment of schizophrenia; and Darigabat, a PAM, which is in Phase 2 proof-of-concept trial in patients with drug-resistant focal onset seizures in epilepsy or focal epilepsy, as we... CERE Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT